Lefkovits J, Topol E J
Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA.
Cleve Clin J Med. 1996 May-Jun;63(3):181-9. doi: 10.3949/ccjm.63.3.181.
The platelet glycoprotein (GP) IIb/IIIa receptor antagonists are powerful new antiplatelet drugs that show promise in reducing complications of coronary angioplasty and acute coronary syndromes.